AGP Picks
View all

Global Wellness Times
Provided by AGP

Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 2, 2026

Varonis Named a Gartner® Peer Insights™ Customers’ Choice for Third Consecutive Year
Jul. 2, 2026

Varonis Named a Gartner® Peer Insights™ Customers’ Choice for Third Consecutive Year

Indeterminate GlobeNewswire
Cannabix Technologies Announces Detection of Methamphetamine and Amphetamine in Human Breath
Jul. 2, 2026

Cannabix Technologies Announces Detection of Methamphetamine and Amphetamine in Human Breath

Indeterminate GlobeNewswire
Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer
Jul. 2, 2026

Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

Indeterminate GlobeNewswire
Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®
Jul. 2, 2026

Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®

Indeterminate GlobeNewswire
LIXTE COMPLETES MERGER WITH NOMAD TRANSPORTABLE POWER SYSTEMS
Jul. 2, 2026

LIXTE COMPLETES MERGER WITH NOMAD TRANSPORTABLE POWER SYSTEMS

Indeterminate GlobeNewswire
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jul. 2, 2026

Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Propanc Biopharma Initiates $5.0 Million Share Repurchase Program
Jul. 2, 2026

Propanc Biopharma Initiates $5.0 Million Share Repurchase Program

Indeterminate GlobeNewswire
New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring
Jul. 2, 2026

New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring

Indeterminate GlobeNewswire
NKGen Biotech to Present at the 2026 BIOCHINA Global Forum on Troculeucel’s Potential in Alzheimer’s Disease and Other Neurodegenerative Conditions
Jul. 2, 2026

NKGen Biotech to Present at the 2026 BIOCHINA Global Forum on Troculeucel’s Potential in Alzheimer’s Disease and Other Neurodegenerative Conditions

Indeterminate GlobeNewswire
OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026
Jul. 2, 2026

OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026

Indeterminate GlobeNewswire
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
Jul. 2, 2026

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Indeterminate GlobeNewswire
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations
Jul. 2, 2026

YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations

Indeterminate GlobeNewswire
Flyte Announces Successful Launch of New Direct-to-Consumer Booking Platform
Jul. 2, 2026

Flyte Announces Successful Launch of New Direct-to-Consumer Booking Platform

Indeterminate GlobeNewswire
Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting
Jul. 2, 2026

Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting

Indeterminate GlobeNewswire
Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026 
Jul. 2, 2026

Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026 

Indeterminate GlobeNewswire
Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention
Jul. 2, 2026

Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention

Indeterminate GlobeNewswire
Die 8. Konferenz zur Entwicklung der Tourismusbranche in der Provinz Heilongjiang steht kurz vor ihrer Eröffnung
Jul. 2, 2026

Die 8. Konferenz zur Entwicklung der Tourismusbranche in der Provinz Heilongjiang steht kurz vor ihrer Eröffnung

Indeterminate GlobeNewswire
El 8.º Congreso de Desarrollo del Sector del Turismo en la Provincia de Heilongjiang está a punto de inaugurarse
Jul. 2, 2026

El 8.º Congreso de Desarrollo del Sector del Turismo en la Provincia de Heilongjiang está a punto de inaugurarse

Indeterminate GlobeNewswire
Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial
Jul. 2, 2026

Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial

Indeterminate GlobeNewswire
Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM
Jul. 2, 2026

Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Global Wellness Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.